* HealthStream Inc HSTM.OQ HSTM.O is expected to show a rise
in quarterly revenue when it reports results on October 25.
* The Nashville, Tennessee-based company is expected to report
a 3.3% increase in revenue to $62.89 million from $60.88 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for HealthStream Inc is for
a loss of 1 cents per share. For the same quarter last year, the
company reported earnings of 8 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for HealthStream
Inc is $29, about 2.4% above its last closing price
of $28.30.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.03 -0.03 0.08 Beat 328.6
Mar. 31 2021 -0.07 -0.06 0.05 Beat 176.9
Dec. 31 2020 0.04 0.04 0.03 Missed -18.2
Sep. 30 2020 0.04 0.04 0.08 Beat 100
Jun. -0.02 0.01 0.11 Beat 2,100
30 2020
Mar. 31 2020 0.16 0.14 0.11 Missed -23.3
Dec. 31 2019 0.07 0.06 0.12 Beat 94.6
Sep. 30 2019 0.06 0.06 0.11 Beat 73.7
This summary was machine generated October 23 at 01:53 GMT. All
figures in US dollars unless otherwise stated